Profile
| Metric | Value |
|---|---|
| Full Name | Insulet Corporation |
| Ticker | NASDAQ: PODD |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Medical Devices |
| Country | United States |
| IPO | |
| Indexes | |
| Website | insulet.com |
| Employees | 3,900 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $278.17 | |
| Price, 1D Change | -0.14% | |
| Market Cap | $20B | |
| - | ||
| PE Ratio | 80.71 | |
| Beta | 0.81 | |
| Revenue | $2B | |
| Revenue, 1Y Change | +22.07% | |
| EPS | $5.78 | |
| EPS, 1Y Change | +96.54% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | $5.78 | |
| EPS Estimate | $4.89 | |
| EPS Est. Change | -15.44% | |
| Revenue | $2.07B | |
| Revenue Estimate | $2.69B | |
| Revenue Est. Change | +29.93% | |
| Current Price | $278.17 | |
| Price Target | - | $379.00 |
| Price Tgt. Change | - | +36.25% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $1.93 | $2.94 | +52.49% | |
| $3.21 | $5.78 | +79.94% | |
| $4.89 | N/A | -15.44% | |
| $6.19 | N/A | +7.01% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $1.65B | $1.70B | +2.97% | |
| $2.05B | $2.07B | +0.81% | |
| $2.69B | N/A | +29.93% | |
| $3.25B | N/A | +56.66% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | +3.80% | |
| Price, 3Y | -9.06% | |
| Market Cap, 1Y | +4.02% | |
| Market Cap, 3Y | -7.97% | |
| Revenue, 1Y | +22.07% | |
| Revenue, 3Y | +88.53% | |
| EPS, 1Y | +96.54% | |
| EPS, 3Y | +2,260.94% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $278.17 | |
| SMA 200 | $303.88 | |
| SMA 200 vs Price | +9.24% | |
| SMA 50 | $306.36 | |
| SMA 50 vs Price | +10.14% | |
| Beta | 0.81 | |
| ATR | $8.44 | |
| 14-Day RSI | 36.37 | |
| 10-Day Volatility | 32.14% | |
| 1-Year Volatility | 39.12% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| Dividends Paid | $0.00 | |
| Payout Ratio | 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $2.07B | |
| EPS | $5.78 | |
| Gross Profit | $1.46B | |
| Gross Margin | 70.48% | |
| Operating Profit | $308.90M | |
| Operating Margin | 14.91% | |
| Net Income | $418.30M | |
| Net Margin | 20.19% | |
| EBITDA | $423.70M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 1.17 | |
| Current Ratio | 3.54 | |
| Quick Ratio | 2.76 | |
| - | ||
| F-Score | 7 | |
| Altman Z-Score | 7.84 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | 80.71 | |
| PS Ratio | 7.76 | |
| PB Ratio | 14.14 | |
| EV/EBITDA | 36.68 | |
| Enterprise Value | N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $1.21B | |
| Cash & Equivalents | $953.40M | |
| Total Assets | $3.09B | |
| Current Assets | $1.89B | |
| Total Liabilities | $1.88B | |
| Current Liabilities | $528.40M | |
| Total Debt | $1.42B | |
| Short Term Debt | $85.90M | |
| Accounts Payable | $19.80M |
Expenses
| Metric | Date | Value |
|---|---|---|
| Total Expenses | $1.76B | |
| Operating Expenses | $1.14B | |
| Cost Of Goods Sold | $611.60M | |
| SG&A | $917.20M | |
| D&A | $80.80M | |
| Interest Expense | $0.00 | |
| Income Tax | -$118.10M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| CFO | $430.30M | |
| CFI | -$146.20M | |
| CFF | -$28.10M | |
| Capex | $134.00M | |
| Free Cash Flow | $296.30M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Bernstein | → | |
| Truist Securities | → | |
| Canaccord Genuity | → | |
| Evercore ISI Group | ||
| Canaccord Genuity | → | |
| Truist Securities | → | |
| RBC Capital | → | |
| BTIG | → | |
| UBS | → | |
| BTIG | → |
Analyst sentiment
Institutional ownership
Screeners with PODD
Data Sources & References
- PODD Official Website www.insulet.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1145197/000114519725000069/0001145197-25-000069-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1145197/000114519725000007/0001145197-25-000007-index.htm
- List of S&P 500 Companies www.spglobal.com/spdji/en/indices/equity/sp-500/#overview
- PODD Profile on Yahoo Finance finance.yahoo.com/quote/PODD
- PODD Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/podd
FAQ
What is the ticker symbol for Insulet Corporation?
The ticker symbol for Insulet Corporation is NASDAQ:PODD
Does Insulet Corporation pay dividends?
No, Insulet Corporation does not pay dividends
What sector is Insulet Corporation in?
Insulet Corporation is in the Healthcare sector
What industry is Insulet Corporation in?
Insulet Corporation is in the Medical Devices industry
What country is Insulet Corporation based in?
Insulet Corporation is headquartered in United States
When did Insulet Corporation go public?
Insulet Corporation initial public offering (IPO) was on May 15, 2007
Is Insulet Corporation in the S&P 500?
Yes, Insulet Corporation is included in the S&P 500 index
Is Insulet Corporation in the NASDAQ 100?
No, Insulet Corporation is not included in the NASDAQ 100 index
Is Insulet Corporation in the Dow Jones?
No, Insulet Corporation is not included in the Dow Jones index
When was Insulet Corporation last earnings report?
Insulet Corporation's most recent earnings report was on November 6, 2025
When does Insulet Corporation report earnings?
The next expected earnings date for Insulet Corporation is February 18, 2026